MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-26-0097160
Brinton Pharmaceuticals Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹215.48 Cr
▲ 15% YoY
Net loss · FY 2025
₹6.35 Cr
Net margin -2.9%
EBITDA · FY 2025
₹1.91 Cr
EBITDA margin 0.9%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.09 Cr
Issued & subscribed
Open charges
₹75.25 Cr
Satisfied ₹81.5 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
508
Provident fund records
About Brinton Pharmaceuticals Limited
Data last updated:
Brinton Pharmaceuticals Limited is a public limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2013PLC148971. Its GSTIN is 27AAFCB6936Q1ZY (Maharashtra). The company holds 14 GST registrations, of which 13 are active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.09 Cr. It is led by directors including Rahul Kundanmal Darda (Managing Director) and Ronak Hemprakash Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at S. No 55/2 Kharadi Taluka Haveli, Pune, Maharashtra, India – 411014.
As per the financials filed for FY 2025, the company reported a revenue of ₹215.48 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹6.35 Cr (net margin -2.9%) and EBITDA of ₹1.91 Cr (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 16% over five years.
The company has about 508 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Brinton Pharmaceuticals. As per MCA filings, the company has open charges of ₹75.25 Cr and satisfied charges of ₹81.5 Cr on record. Court records list 14 cases involving the company, including 6 filed by the company and 8 filed against it; 8 cases are pending. The company has 10 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹74.8 Cr; the latest was in August 2021. The company has 7 MSME Form 1 returns on record between 2019 and 2024, listing 267 overdue payments to 71 micro and small suppliers.
Brinton Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0097160). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brintonhealth.com.
Company details
CIN U24232PN2013PLC148971
Registration Number 148971
Incorporation Date 27 September 2013
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-26-0097160
Key People
Rahul Kundanmal Darda Managing Director Ronak Hemprakash Shah Director Chaitali Rahul Darda Director Recognitions & Rankings of Brinton Pharmaceuticals
Contact details
Brinton Pharmaceuticals Limited's registered office is in Pune, Maharashtra. Its website is brintonhealth.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS. No 55/2 Kharadi Taluka Haveli, Pune, Maharashtra, India – 411014
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Brinton Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Brinton Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Brinton Pharmaceuticals operates one associated brand: Brinton Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | brintonhealth.com |
Business activity
The main business activity of Brinton Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Brinton Pharmaceuticals Limited, buy the company report.
Financials of Brinton Pharmaceuticals Limited
FY 2024 filings availableBrinton Pharmaceuticals Limited reported revenue of ₹215.48 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹215.48 Cr ▲ 15%
Net loss · FY 2025
₹6.35 Cr margin -2.9%
EBITDA · FY 2025
₹1.91 Cr margin 0.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 27%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 70%
3 years · compounded
▼ 19%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 15% growth in the latest year. EBITDA fell 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brinton Pharmaceuticals Limited, buy the company report.
Board of directors of Brinton Pharmaceuticals Limited
Brinton Pharmaceuticals has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Kundanmal Darda Also directs: Bricks & Mortar Infrastructure LLP, Brinton Healthcare Limited, Human Method Ergonomics Private Limited and 2 more | Managing Director | 27 Sep 2013 | 13 Years 0 Months | Current |
| Ronak Hemprakash Shah Also directs: Deshpande & Shah Legal Advisory LLP | Director | 28 Mar 2024 | 2 Years 6 Months | Current |
| Chaitali Rahul Darda | Director | 27 Sep 2013 | 13 Years 0 Months | Current |
| Shivani Bhasin Also directs: Brinton Healthcare Limited, Hikal Limited, Gynoveda Femtech Private Limited and 3 more | Nominee Director | 13 Jun 2019 | 7 Years 4 Months | Current |
| Visalakshi Chandramouli Also directs: Brinton Healthcare Limited, Sakar Healthcare Limited, Linux Laboratories Private Limited and 4 more | Nominee Director | 30 Mar 2017 | 9 Years 6 Months | Current |
| Sudeep Chhallani Also directs: Chhallani Care Foundation | Director | 28 Mar 2024 | 2 Years 6 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
Brinton Pharmaceuticals Limited is audited by M S K A & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S K A & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Brinton Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Brinton Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹75.25 Cr
Satisfied charges
₹81.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2025 | 101090172 | Others | ₹75 Cr | Open | |
| 04 Aug 2020 | 100379186 | Others | ₹25 Lakh | Open | |
| 04 Sep 2024 | 100974582 | Others | ₹4 Cr | Satisfied | |
| 27 Jun 2023 | 100750207 | Others | ₹7.5 Cr | Satisfied | |
| 09 Jun 2023 | 100730089 | Others | ₹3 Cr | Satisfied |
To see the full charge records of Brinton Pharmaceuticals Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Brinton Pharmaceuticals Limited has 10 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹74.8 Cr; the latest was in August 2021.
Total deals
10
Funding rounds
5
Secondary share transfers
3
Rights issues
2
Disclosed funding
₹74.8 Cr
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Funding round · Series D | ₹5 Cr | Investors: Winner Family Private Trust |
| Dec 2020 | Funding round · Series C | ₹4.5 Cr | Investors: an individual |
| Jun 2019 | Funding round · Series B | ₹40 Cr | Investors: India Alternatives Private Equity |
| Nov 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Marigold Investments Limited |
| Aug 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Marigold Investments Limited |
To see the full deal history of Brinton Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Brinton Pharmaceuticals Limited has 14 court cases on record: 6 filed by Brinton Pharmaceuticals, 8 filed against it. 8 cases are pending and 6 are disposed.
Total cases
14
Filed by the company
6
Filed against the company
8
Pending
8
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 5 | 8 |
| High courts | 3 | 3 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Commercial suit | Filed against the company by Wings Pharmaceuticals P Ltd | Pending |
| District court, South East, Delhi | Commercial suit | Filed against the company by Lifestar Pharma Private Limited | Pending |
| High Court | Court case (COMMP) | Filed against the company by Mankind Pharma Limited Kalpesh Joshi Associates | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed against the company by Mankind Pharma Limited | Disposed |
| High Court of Delhi | Court case (FAO (COMM)) | Filed against the company by Mankind Pharma Limited | Disposed |
To see the full case history of Brinton Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Brinton Pharmaceuticals Limited has 7 MSME Form 1 returns on record between 2019 and 2024, listing 267 overdue payments to 71 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 71)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Wederm Private Limited | |||
| Vishnu Enterprises CR | |||
| Royal Orchid Hotels Limited | |||
| Enicar Pharmaceuticals Private Limited | |||
| Vardhaman Meditrade LLP |
To see the full MSME payment records of Brinton Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Brinton Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Brinton Healthcare Limited | U24297PN2019PLC187750 |
To see the full group structure of Brinton Pharmaceuticals Limited, buy the company report.
Employees & EPFO
Brinton Pharmaceuticals Limited has a workforce of 508 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
508
Active EPFO establishments
1
Employee growth
13.65%
GST
Brinton Pharmaceuticals has 14 GST registrations: 13 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
14
Active
13
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCB6936Q1ZY | Maharashtra | Active | 01 Jul 2017 |
| 06AAFCB6936Q1Z2 | Haryana | Active | 15 Feb 2019 |
| 23AAFCB6936Q1Z6 | Madhya Pradesh | Active | 05 Feb 2020 |
| 29AAFCB6936Q1ZU | Karnataka | Active | 26 Mar 2020 |
To see the full GST registrations and return filing status of Brinton Pharmaceuticals Limited, buy the company report.
Recent activity
Brinton Pharmaceuticals Limited has 13 board changes on record since 2013: 7 appointments and 6 cessations. The latest: Ronak Hemprakash Shah was appointed as Director on 28 Mar 2024.
Charges
A charge registered on 30 Aug 2021 via Charge ID 100514652 with Others was fully satisfied on 17 Apr 2025.
Charges
A charge registered on 09 Jun 2023 via Charge ID 100730089 with Others was fully satisfied on 16 Apr 2025.
Charges
A charge registered on 31 Jan 2023 via Charge ID 100673056 with Others was fully satisfied on 15 Apr 2025.
Charges
A charge registered on 04 Sep 2024 via Charge ID 100974582 with Others was fully satisfied on 05 Apr 2025.
Charges
A charge registered on 27 Jun 2023 via Charge ID 100750207 with Others was fully satisfied on 01 Apr 2025.
Charges
A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101090172 was registered on 27 Mar 2025.
Charges
A charge with Others of Rs. 15.00 Cr registered on 31 Jan 2023 with Charge ID 100673056 was modified on 27 Feb 2025.
AGM
Brinton Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100974582 was registered on 04 Sep 2024.
Charges
A charge with Others of Rs. 7.50 Cr registered on 27 Jun 2023 with Charge ID 100750207 was modified on 29 Jul 2024.
Filing
Brinton Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Charges
A charge with Others of Rs. 17.00 Cr registered on 30 Aug 2021 with Charge ID 100514652 was modified on 30 Mar 2024.
27 earlier events are in the company report.
News
Frequently asked questions
Brinton Pharmaceuticals is an active public limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 September 2013 (13+ years old) and is registered under CIN U24232PN2013PLC148971.
Brinton Pharmaceuticals has 7 current directors:
- Rahul Kundanmal Darda - Managing Director
- Ronak Hemprakash Shah - Director
- Chaitali Rahul Darda - Director
- Shivani Bhasin - Nominee Director
- Visalakshi Chandramouli - Nominee Director
- Sudeep Chhallani - Director
- Vijey Christopher James Victor - Director
The latest financial statements of Brinton Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Brinton Pharmaceuticals is 27AAFCB6936Q1ZY, registered in Maharashtra. The company has 14 GST registrations in all, of which 13 are active and 1 is cancelled or inactive. Other active GSTINs include 06AAFCB6936Q1Z2 (Haryana), 23AAFCB6936Q1Z6 (Madhya Pradesh), 29AAFCB6936Q1ZU (Karnataka).
The CIN (Corporate Identification Number) of Brinton Pharmaceuticals is U24232PN2013PLC148971. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brinton Pharmaceuticals has 14 court cases on record: 6 filed by the company and 8 filed against it. 8 are pending. Most are in the district courts.
Brinton Pharmaceuticals was incorporated on 27 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Pune.
Brinton Pharmaceuticals has 10 deals on record (5 funding rounds, 3 secondary share transfers, 2 rights issues), with disclosed funding of ₹74.8 Cr; the latest was in August 2021.
Ronak Hemprakash Shah was appointed as Director on 28 Mar 2024. Sudeep Chhallani was appointed as Director on 28 Mar 2024. Rahul Kundanmal Darda ceased to be Director on 01 Apr 2021. Brinton Pharmaceuticals has 13 board changes on record in total.
Yes, Brinton Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-26-0097160).
Brinton Pharmaceuticals has 7 MSME Form 1 returns on record between 2019 and 2024, listing 267 overdue payments to 71 micro and small suppliers. The latest return was filed on 30 Apr 2024.